X-rays to detect changes to the spine and pelvis MRI scan to examine the sacroiliac joints ultrasound to show peripheral joint and tendon inflammation blood tests to reveal markers of inflammation ...

Ankylosing spondylitis causes chronic back pain and joint fusion, affecting millions. Learn the early warning signs and what triggers this disease.

Treatment for ankylosing spondylitis (AS) aims to achieve and maintain remission. When in remission, disease activity such as inflammation, joint stiffness, and pain is low or minimal. AS is a ...

The first Saturday of May each year marks World Ankylosing Spondylitis (AS) Day, raising awareness of the 54 million patients ...

According to a 20-year follow-up study from 2017, people who received a diagnosis of IBD were more likely to report ankylosing spondylitis, axSpA, and inflammatory back pain in the 20 years after ...

Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints (those between the spine and hipbone). Less commonly, AS can affect other joints ...

Ankylosing spondylitis (AS) is a type of inflammatory arthritis that affects the joints and ligaments in the spine. Early signs that you may have AS include pain and stiffness in the lower back ...

Infliximab (Remicade) IL-17 inhibitors. Two are FDA-approved for ankylosing spondylitis: ixekizumab (Taltz) and secukinumab (Cosentyx). They target different cytokines than the TNF inhibitors.